secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annexon, Inc. (ANNX)
CIK:        0001528115
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001193125-24-157454
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Annexon prices $125M public offering of common stock and pre-funded warrants
----------------------------------------------------------------------------

- Priced 13,001,120 shares at $6.25/sh and 7M pre-funded warrants at $6.249/sh; gross proceeds $125M.
- Net proceeds expected ~$116.9M after underwriting discounts and expenses; offering closed June 7, 2024.
- Underwriters granted 30-day option to purchase up to 3,000,168 additional shares.
- J.P. Morgan, Jefferies, TD Cowen, BofA Securities and Wells Fargo Securities served as joint book-running managers.
- Funds will support development of classical complement-mediated neuroinflammatory therapies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1528115/000119312524157454/0001193125-24-157454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1528115/000119312524157454/d841004d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-157454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer